The 65 rating InvestorsObserver gives to Rhythm Pharmaceuticals Inc (RYTM) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 76 percent of stocks in the Biotechnology industry, RYTM’s 65 overall rating means the stock scores better than 65 percent of all stocks.
RYTM has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on RYTM!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 65 would rank higher than 65 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Rhythm Pharmaceuticals Inc Stock Today?
Rhythm Pharmaceuticals Inc (RYTM) stock is trading at $43.58 as of 12:34 PM on Thursday, Mar 28, an increase of $1.78, or 4.27% from the previous closing price of $41.79. The stock has traded between $41.79 and $43.66 so far today. Volume today is low. So far 177,561 shares have traded compared to average volume of 568,256 shares.
Click Here to get the full Stock Report for Rhythm Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
